Prime-boost strategies for malaria vaccine development.

Prime-boost strategies for malaria vaccine development.

Malaria is an intracellular pathogen, for which an effective vaccine is likely to require induction of cell-mediated immunity. Immunisation approaches that stimulate strong and persistent levels of effector T-cells are being sought by many researchers. DNA vaccines, recombinant protein and viral vec...

Detaylı Bibliyografya
Asıl Yazarlar:	Dunachie, S, Hill, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

Prime-boost vectored malaria vaccines: progress and prospects.
Yazar:: Hill, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
Yazar:: Hill, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
Yazar:: Moore, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
Yazar:: Gilbert, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
Yazar:: Draper, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prime-boost immunisation strategies for tuberculosis.
Yazar:: Mcshane, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
Yazar:: Vuola, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
Yazar:: Dunachie, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
Yazar:: Venkatraman, N, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
Yazar:: Ramirez-Valdez, RA
Baskı/Yayın Bilgisi: (2021)

Novel prime-boost vaccine strategies against HIV-1
Yazar:: Jean-Louis Excler, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
Yazar:: Keating, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.
Yazar:: George Jiang, ve diğerleri
Baskı/Yayın Bilgisi: (2009-08-01)

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
Yazar:: Moorthy, V, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Heterologous Prime-boost COVID-19 Vaccination
Yazar:: Vishal R. Tandon, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.
Yazar:: Hanke, T
Baskı/Yayın Bilgisi: (2014)

Prime-boost AIDS Vaccine Strategies Based on Replication-Competent Adenovirus Recombinants
Yazar:: Srivastava Indresh, ve diğerleri
Baskı/Yayın Bilgisi: (2005-12-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
Yazar:: Jaejo Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Evaluation of prime boosting vaccination strategy using newly constructed tuberculosis vaccine candidates in mice
Yazar:: Zakaria, Nurazwana
Baskı/Yayın Bilgisi: (2013)

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
Yazar:: Schwarz, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.
Yazar:: Rogers, W, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis
Yazar:: Mathilde Bahuaud, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
Yazar:: Jean-Louis Palgen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Prime-boost immunization strategies for infectious diseases.
Yazar:: Mcshane, H
Baskı/Yayın Bilgisi: (2002)

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
Yazar:: Sklar, MJ, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
Yazar:: Antonia Radaelli, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.
Yazar:: Schneider, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Modeling the Dependence of Immunodominance on T Cell Dynamics in Prime-Boost Vaccines
Yazar:: Clemente Fernandez Arias, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Can existing unrelated vaccines boost a COVID-19 vaccine prime?
Yazar:: Nathaniel Hupert, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
Yazar:: Nur Ayuni, Kadir
Baskı/Yayın Bilgisi: (2008)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
Yazar:: Gilbert, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
Yazar:: McConkey, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
Yazar:: Wyatt LS, ve diğerleri
Baskı/Yayın Bilgisi: (2009-10-01)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Yazar:: Shaw, RH, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Statistical considerations for the platform trial in COVID-19 vaccine priming and boosting
Yazar:: Michael Dymock, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
Yazar:: Om Prakash Choudhary, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Malaria vaccine developments.
Yazar:: Moorthy, V, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
Yazar:: Goodman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

MIG and the regulatory cytokines IL-10 and TGF-[beta]1 correlate with malaria vaccine immunogenicity and efficacy.
Yazar:: Dunachie, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy
Yazar:: Dunachie, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)